Navigation Links
Encision Reports Profitable Fourth Quarter and Fiscal Year 2011 Results
Date:6/1/2011

ay cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase net sales through the Company's distribution channels, its ability to compete successfully against other manufacturers of surgical instruments, insufficient quantity of new account conversions, insufficient cash to fund operations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission. Readers are encouraged to review the risk factors and other disclosures appearing in the Company's Annual Report on Form 10-K for the year ended March 31, 2010 and subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements, whether as a result of the receipt of new information, future events, or otherwise.

CONTACT:  Marcia McHaffie, Encision Inc., 303-444-2600, mmchaffie@encision.comEncision Inc.Condensed Balance Sheets(Amounts in thousands)(Audited)March 31, 2011March 31, 2010ASSETSCash and cash equivalents$
20$
4Accounts receivable, net1,1601,286Inventories, net2,6042,477Prepaid expenses7443 Total current assets3,9583,920Equipment, net1,1691,149Patents, net260266Other assets2424 Total assets$ 5,411$ 5,359LIABILITIES AND SHAREHOLDERS' EQUITYAccounts payable$
74$
84Accrued compensation261405Other accrued liabilities287277Line of credit435-- Total current liabilities1,6571,366Line of credit--350Common stock and additional paid-in capital19,78319,677Accumulated (deficit)(16,029)(16,034) Total shareholders' equity3,7543,643 Total liabilities and shareholders' equity$ 5,411$  5,359Encision Inc.Condensed Statements of Operations(Amounts in thousands, ex
'/>"/>

SOURCE Encision Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Encision Reports Profitable Third Fiscal Quarter Results
2. Encision and HealthTrust Purchasing Group Sign Purchasing Agreement
3. Encisions Technology Recognized as A Means to Eliminate Surgery Burns
4. Encisions Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. Spherix Reports Second Quarter Earnings
7. Tapestry Reports Second Quarter 2007 Results
8. Callisto Reports on Second-Quarter 2007 Milestones
9. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Biopharmaceutical Industry Leads Manufacturing Sector in ... on top as the country,s manufacturing leader in innovation ... ndp│analytics. According to the  analysis , the industry had ... last decade, accounting for 27 percent of average annual ... Short Video on Medicare Part D - Medicare ...
(Date:3/27/2015)... 27, 2015 The Temple Health & Bioscience District ... 5,000-square-foot building at 1802 South First St. in the Temple ... the City of Temple to receive ... the Central Texas Veterans Health Care System, the new facility ... early stage biotechnology and life science companies. ...
(Date:3/27/2015)... A new report from Kalorama Information says that ... Chile , Colombia ... IVD firms.  The healthcare research firm said that while ... the Latin American continent with a population of over 200 ... However, the country,s regional economic clout does not necessarily ensure ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... 24, 2011 Vanda Pharmaceuticals Inc. (Nasdaq: ... Repella as Senior Vice President, Chief Commercial Officer of ... 25 years of experience in the biotech/pharmaceutical industry, including ... development and commercial operations.   "We are ...
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ... 15mg, and 20mg strengths of olanzapine orally disintegrating tablets, ... According to IMS Health data, annual sales in the ... Important information about olanzapine ODT ...
Cached Medicine Technology:Vanda Pharmaceuticals Appoints Chief Commercial Officer 2Par Pharmaceutical Begins Shipment of Generic Zyprexa® Zydis® 2
(Date:3/28/2015)... 28, 2015 Could genetic code determine ... study by researchers at the Harvard T.H. ... the support of the Coffee and Caffeine Genetics Consortium ... this past fall, the study—one of several recent HSPH ... data from more than 120,000 regular coffee drinkers of ...
(Date:3/28/2015)... a bite of warm, gooey pepperoni pizza, and your ... stomach, ready to break down your meal. In many ... amok, triggering a burning sensation in the chest. Heartburn ... Americans have heartburn at least once a month. The ... can be stopped. , Heartburn or acid reflux symptoms ...
(Date:3/28/2015)... York, New York (PRWEB) March 28, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. Bard, ... litigation underway in U.S. District Court, Southern District ... S. Grand, is serving on the Plaintiffs’ Steering ... 24th, the Court has granted certain defendants named ...
(Date:3/28/2015)... Emergency Medical Care (EMC), a New ... recently commemorated its three-year anniversary of being the only ... to 24-hour urgent care, Emergency Medical Care offers its ... time, Emergency Medical Care’s Urgent Care NYC ... eye injuries, ear infections, fevers, insect bites, burns, animal ...
(Date:3/28/2015)... March 28, 2015 An article in ... which could prove critical to organizations that deal with ... critical aspect of data security, is worsening . ... security report, every major category out of the twelve ... testing. “With all the craziness that has gone on ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4
... associated with VIB and KU Leuven, succeeded in undoing ... leads to Parkinson,s using vitamin K2. His discovery gives ... collaboration with colleagues from Northern Illinois University (US) and ... the authorative journal Science ., "It appears from ...
... HealthDay Reporter , THURSDAY, May 10 (HealthDay News) ... cells to enhance their healing potential may help people with ... suggests. Researchers developed the treatment by culturing a ... increase the amount of immune cells and stem cells that ...
... , THURSDAY, May 10 (HealthDay News) -- Inducing labor after ... can reduce an infant,s risk of death before, during or ... a new study says. However, babies born after induced ... hospital,s infant intensive care unit, said researchers led by Sarah ...
... THURSDAY, May 10 (HealthDay News) -- A new weight-loss ... and Drug Administration showed promising results in a recent ... a combination of the drugs phentermine and topiramate, experienced ... health problems, the study found. The findings were reported ...
... is a major first line defense against breast cancer. ... A study published in BioMed Central,s open access journal ... signatures, for TOP2A and β-tubulin can be used to ... of personalized medicine in cancer treatment is to target ...
... A review of 30 years of life-threatening asthma cases in ... admissions for the condition have dropped 74 percent. The study, ... University Hospital between 1980 and 2010, also showed intubation in ... in longer hospital stays. UT Medicine is the clinical ...
Cached Medicine News:Health News:Vitamin K2: New hope for Parkinson's patients? 2Health News:Stem Cell Study Shows Promising Results Against Heart Failure 2Health News:Stem Cell Study Shows Promising Results Against Heart Failure 3Health News:Induced Labor Late in Pregnancy Has Pros, Cons 2Health News:New Weight-Loss Drug Shows Promise in Trial 2Health News:New Weight-Loss Drug Shows Promise in Trial 3Health News:ICU stays for worst asthma drop 74 percent, review finds 2
... supplied on Smart Cards. Insert the card and ... and turns itself off after the programmed time. ... duration of treatments. Simply provide your patient with ... their progress on the next visit.,The initial set ...
... timely, high-quality and accurate,ECG results ... The,Quinton Eclipse Premier allows you ... results,and make a diagnosis quicker ... capabilities.,Workload is further streamlined with ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
... profile) is specifically designed for use on ... The MicroTouch LP attaches to tables on ... the user complete freedom to move the ... loss of position of the instrument or ...
Medicine Products: